MSB 7.22% 90.0¢ mesoblast limited

seekingalpha comments, page-3

  1. 521 Posts.
    lightbulb Created with Sketch. 1481
    Hi Guys,

    Tejano- are these the same US critics that are long on Athersys($43m mkt cap) and Citori ($175m mkt cap) and just are bewildered that an Aussie grown company is the world leader in the Regenerative Medicine industry.

    http://seekingalpha.com/article/266853-athersys-grossly-undervalued-given-its-potential

    Mtom - I agree with Market volatily and IMO just good to know MSB is a progressive company with world class management and excellent clinical results(to date). The recent ASX announcement (as noted by Vinn) truly is an exciting opportinity by MSB to showcase Revascor to the world.

    GO AUSSIE GO !!!!

    DYOR before making any decisions.
    Good weekend to all.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.